Skip to main content
OpenTrials
Completed

NCT Number: NCT06195839

Building Engagement Using Financial Incentives Trial - Hypertension

The goal of this pilot clinical trial is to determine feasibility and explore whether immediate versus delayed patient financial incentives improve patient engagement with self-monitoring of blood pressure in patients with uncontrolled hypertension at Louisiana federally qualified health centers (FQHCs). The main questions it aims to answer are:

* Do patients randomized to receive financial incentives on a weekly basis during the study (immediate) have better adherence to blood pressure self-monitoring compared to patients randomized to receive financial incentives at the end of the study (delayed)? * Do patients randomized to immediate financial incentives have better blood pressure control compared to patients randomized to delayed incentives?

Participants will:

* attend a baseline visit to measure blood pressure, respond to a baseline survey, and receive remote patient monitoring devices and instructions to take home with them (home blood pressure monitor, wrist-worn sensor to track sleep activity, and associated apps) * receive a random allocation to one of two groups: control condition (receive cash incentives at the end of the study for measuring blood pressure as instructed) or intervention condition (receive weekly cash incentives throughout the study for measuring blood pressure as instructed) * use remote patient monitoring devices during a two month study period, receive weekly reports on adherence to blood pressure monitoring, and receive weekly financial incentives (intervention condition only) * attend one follow-up visit at 2 months to measure their blood pressure, complete a follow-up survey, return the remote patient monitoring devices, and receive financial incentives for blood pressure monitoring (control condition only)

Researchers will compare the immediate and delayed incentive groups to see if there are differences in blood pressure monitoring adherence rates and blood pressure control.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Adherence, Patient Behavior Cardiovascular Diseases Health Behavior Healthcare Patient Acceptance Patient Acceptance of Health Care Patient Compliance Patient Engagement Patient Participation Treatment Adherence and Compliance Vascular Diseases

Age range

40 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CommuniHealth Services, Bastrop, Louisiana, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥40 years
  • receive care at a participating FQHC
  • taking blood pressure medication
  • uncontrolled blood pressure at most recent clinic visit (systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥80 mm Hg)
  • ability to understand and speak English
  • able to access a smartphone

Exclusion criteria

  • currently participating in another clinical trial or research study on blood pressure, medication-taking, or sleep
  • unable or unwilling to give informed consent

Treatment and study plan

Remote Patient Monitoring

Behavioral

Participants will be given a home blood pressure machine and instructed to take their blood pressure twice/day (once in the morning and once at night) for the duration of the 2-month study. Blood pressure values will be immediately available in their patient-facing portal accessible via smartphone app, and patients will receive weekly feedback reports on their adherence to the home blood pressure monitoring protocol. Patients' blood pressure values will also be accessible to their clinical care team via an administrator portal, which will alert clinicians of any values above or below pre-specified clinical thresholds.

Self-monitoring of hypertension-related factors

Behavioral

As part of self-monitoring of hypertension-related factors, the blood pressure monitoring patient-facing app will also prompt patients daily to report whether or not they took their blood pressure medication. in addition, participants will be provided with a wrist-worn sensor and instructed to wear it at night to track their sleep activity. Data on sleep activity will be available to patients through a separate patient-facing app accessible on their smartphone.

Immediate financial incentives

Behavioral

Weekly financial incentives for measuring their blood pressure as instructed (up to $25/week: $5/day for up to 5 days/week)

Delayed financial incentives

Behavioral

Financial incentives for measuring their blood pressure as instructed in one payment at the end of the study (up to $25/week: $5/day for up to 5 days/week)

Primary outcomes

  1. Between-group difference in weekly adherence to blood pressure monitoring

    Time frame: 8 weeks

    Weekly adherence to blood pressure monitoring will be defined as the number of days that the participant used the home blood pressure monitor at least once, captured in the blood pressure monitoring app usage data.

Secondary outcomes

  1. Between-group mean difference in change in systolic blood pressure

    Time frame: 8 weeks

    Blood pressure will be measured at baseline and 8-week follow-up by a certified Clinical Research Coordinator using the average of three seated blood pressure measurements and in accordance with American Heart Association (AHA) guidelines.

  2. Between-group mean difference in change in diastolic blood pressure

    Time frame: 8 weeks

    Blood pressure will be measured at baseline and 8-week follow-up by a certified Clinical Research Coordinator using the average of three seated blood pressure measurements and in accordance with American Heart Association (AHA) guidelines.

  3. Between-group difference in the proportion with blood pressure control (<130/80 mm Hg)

    Time frame: 8 weeks

    Blood pressure will be measured at baseline and 8-week follow-up by a certified Clinical Research Coordinator using the average of three seated blood pressure measurements and in accordance with American Heart Association (AHA) guidelines. Blood pressure control will be defined as systolic <130 mm Hg and diastolic <80 mm Hg.

  4. Between-group difference in the proportion with systolic blood pressure control (<130 mm Hg)

    Time frame: 8 weeks

    Blood pressure will be measured at baseline and 8-week follow-up by a certified Clinical Research Coordinator using the average of three seated blood pressure measurements and in accordance with American Heart Association (AHA) guidelines. Systolic blood pressure control will be defined as systolic <130 mm Hg.

Other outcomes

  1. Number of patient approached for recruitment

    Time frame: 3 months

    Number of patients with reachable phone numbers or approached in clinic

  2. Number of patients assessed for eligibility

    Time frame: 3 months

    Number of patients who begin eligibility screener

  3. Number of patients enrolled

    Time frame: 3 months

    Number of patients who consent and are randomized

  4. Number of patients who receive intended treatment

    Time frame: 2 months

    Proportion of total possible financial incentive received

Sponsors and collaborators

Lead sponsor

Tulane University

Other

Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

Registry information

Acronym: BENEFIT-H

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jan 8, 2024
Registry last updated
Sep 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.